Policy Comments

The priority legislative and regulatory issues that the Cancer Policy Institute focuses on are driven by policy pillars that are centered around the values, needs, and preferences of individuals impacted by cancer. We work in conjunction with patients, patient advocacy organizations, medical associations, and other stakeholders to advance policies aimed at improving access to, affordability of, and quality of care across the cancer continuum.

    CSC Comments To HHS, CMS, And CCIIO On Notice Of Benefit And Payment Parameters (NBPP) 2023 Proposed Rule (January 2022)
    Access to Affordable, Comprehensive Care, Affordable Care Act, Copay Accumulators, Medicare, Medicaid, and Private Health Insurance Coverage, Out of Pocket Costs, Anti-discrimination, Health Equity
    CSC Letter Regarding Oregon's 1115 Demonstration Waiver (January 2022)
    Medicaid Section 1115 Waivers, Medicare, Medicaid, and Private Health Insurance Coverage
    CSC Letter Regarding The Georgia Access Model (January 2022)
    Section 1332 Waivers
    Group Letter In Support Of The Accelerating Kids’ Access To Care Act (January 2022)
    Medicare, Medicaid, and Private Health Insurance Coverage
    Group Letter To Congress Regarding Expired Telehealth Policy (January 2022)
    Telehealth, COVID-19
    Group Letter To Congressional Leadership Re: Establishing A Pathway For Comprehensive Telehealth Reform (January 2022)
    Telehealth, Medicare, Medicaid, and Private Health Insurance Coverage, COVID-19
    Group Letter To Energy And Commerce Full Committee And Health Subcommittee On Antimicrobial Resistance (AMR) (January 2022)
    Access to Innovative Treatment, Public Health, COVID-19
    Group Letter To HHS, CMS, And CCIIO On Notice Of Benefit And Payment Parameters (NBPP) 2023 Proposed Rule (January 2022)
    Access to Affordable, Comprehensive Care, Affordable Care Act, Copay Accumulators, Medicare, Medicaid, and Private Health Insurance Coverage, Out of Pocket Costs, Anti-discrimination, Health Equity
    Group Letter Urging HHS And CMS To Expand Access To At Home COVID 19 Tests For Medicare Beneficiaries (January 2022)
    COVID-19, Medicare, Medicaid, and Private Health Insurance Coverage
    CSC Comments To Representatives DeGette And Upton On Cures 2.0 Act (December 2021)
    Patient Experience, 21st Century Cures, FDA, Clinical Trials, Access to Innovative Treatment, Telehealth, Health Equity